SCHEMBL19009744

SCHEMBL19009744

c1cncc(-c2cc(-c3ccc(-c4nc5c6ccccc6c6ccccc6c5c5c4ccc4cccnc45)cc3)cc(-c3cccnc3)c2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
CYP11B1 P15538 7/20 0.44
CYP19A1 P11511 6/20 0.44
CYP11B2 P19099 6/20 0.44
CYP17A1 P05093 1/20 0.44
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39
CYP2A6 P11509 1/20 0.39
DHODH Q02127 1/20 0.37
CYP1A1 P04798 1/20 0.37
CYP1A2 P05177 1/20 0.37
PRKDC P78527 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19009748 0.96 CYP11B1 (0.43) KDM4ENPC1RAB9AL3MBTL1CYP11B1
SCHEMBL19009702 0.91 CYP11B1 (0.46) KDM4ENPC1RAB9AL3MBTL1CYP11B1
SCHEMBL19009730 0.88 L3MBTL1 (0.45) KDM4ENPC1RAB9AL3MBTL1CYP11B1
SCHEMBL19009695 0.87 CYP11B1 (0.46) KDM4ENPC1RAB9ACYP11B1CYP19A1
SCHEMBL19009692 0.85 CYP11B1 (0.47) KDM4ENPC1RAB9AL3MBTL1CYP11B1
SCHEMBL18748077 0.84 KDM4E (0.43) KDM4ENPC1RAB9AL3MBTL1CYP11B1
SCHEMBL19009715 0.84 CYP11B1 (0.42) KDM4ENPC1RAB9AL3MBTL1CYP11B1
SCHEMBL19009729 0.84 CYP11B1 (0.46) KDM4ENPC1RAB9AL3MBTL1CYP11B1
SCHEMBL19009746 0.82 CYP11B1 (0.43) KDM4ENPC1RAB9AL3MBTL1CYP11B1
SCHEMBL19009737 0.82 MEN1 (0.42) KDM4ENPC1RAB9AL3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170179407-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed
US-20170179407-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170179407-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 KDM4E 3813/4885NPC1 1611/4885RAB9A 2881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.